Welcome to the Washington University
Co-Clinical Imaging Research Resource
The objective of the C2IR2 is to develop, optimize, and implement bi-directional translational quantitative imaging (QI) methodologies to advance the science and clinical practice of precision medicine.
To accomplish this objective, we will:
- Optimize the use of animal models of cancer (e.g., PDX) in oncologic imaging.
- Develop and implement bi-directional (preclinical-clinical) QI and radiomic pipelines to assess tumor heterogeneity and predict response to therapy.
- Integrate QI and radiomic image features with multi-scale analytic data (-OMICS, path) via machine learning algorithms to enhance prediction of response to therapy.
What Can I Find On This Site?
Data collection and operational procedures for three resource cores will be made available here: Preclinical Imaging, Co-Clinical Studies, and Quantitative Imaging Phenotypes.
The C2IR2 works in tandem with co-clinical research projects such as the Co-Clinical Trial in Triple Negative Breast Cancer Patients with Genoproteomic Discovery.
As publications and public study data become available, the C2IR2 will publish or link to those resources here.